• Publications
  • Influence
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
BACKGROUND & AIMS Hepatosplenic T-cell lymphoma (HSTCL) is a rare and usually fatal lymphoma that primarily affects men younger than 35 years old. Treatment of patients with inflammatory bowelExpand
  • 386
  • 8
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
BACKGROUND & AIM Retrospective studies show an association between proton pump inhibitor (PPI) therapy and spontaneous bacterial peritonitis (SBP). We investigate the relationship between PPI and SBPExpand
  • 80
  • 3
Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure
Background and aims Classical features of autoimmune hepatitis (AIH) may be altered during the abrupt onset of the disease. Corticosteroid therapy can be life-saving, but its use in the fulminantExpand
  • 35
  • 3
Liver transplantation in acute liver failure: A challenging scenario.
Acute liver failure is a critical medical condition defined as rapid development of hepatic dysfunction associated with encephalopathy. The prognosis in these patients is highly variable and dependsExpand
  • 39
  • 2
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir
Registration studies show entecavir (ETV) to be effective and safe in NUC‐naïve patients with chronic hepatitis B, but relapse rates after treatment discontinuation have not been well established.Expand
  • 23
  • 2
A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
INTRODUCTION AND AIM A pro-oncogenic intestinal microbiome was observed in murine models; however, no specific microbiome in patients with hepatocellular carcinoma (HCC) has been reported. We aimedExpand
  • 15
  • 2
Hepatotoxicity induced by coxibs: how concerned should we be?
ABSTRACT Introduction: The selective inhibitors of COX-2, coxibs, are nonsteroidal anti-inflammatory drugs (NSAIDs) that have much better gastrointestinal safety profile as compared withExpand
  • 20
  • 2
Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice.
BACKGROUND AND AIMS Entecavir (ETV) is effective and safe in patients with chronic hepatitis B in the short term, but its long term efficacy and safety has not been established. MATERIAL ANDExpand
  • 11
  • 2
  • PDF
Neurological events after liver transplantation: a single‐center experience
The aim of this study was to identify potential risk factors linked to neurologic events (NE) occurring after liver transplantation (LT) and use them to construct a model to predict such events. FromExpand
  • 6
  • 2
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
Noncirrhotic portal hypertension (NCPH) represents a relatively infrequent group of conditions that causes portal hypertension in the absence of cirrhosis. An association between NCPH and patientsExpand
  • 26
  • 1